3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
56
Phase 1/2
28
Phase 3
22
Phase 1
19
Phase EARLY_PHASE1
4
Phase 4
2
Phase 2/3
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Interventions
Dexamethasone
12
Bevacizumab
9
Saline Solution
8
Bupivacaine
8
Tobacco Use Cessation Devices
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
7
Rituximab
6
Prednisone
6
Letrozole
6
Lenalidomide
6
Fluorouracil
6
Cisplatin
6
Carboplatin
6
pembrolizumab
5
Sodium Chloride
5
Ropivacaine
5
Human Papillomavirus Recombinant Vaccine nonavalent
5
Trastuzumab
4
Tamoxifen
4
Standard of Care
4
Propofol
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
Esomeprazole
4
Enoxaparin
4
Doxorubicin
4
Bortezomib
4
Bismuth
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
abemaciclib
×
1 year
×
Clear all
NCT07487129
2026-03-23
Clinical and P
Beni-Suef University
Phase 4
Completed
206 enrolled
NCT06169371
2026-01-14
BRE-09
University of Illinois at Chicago
Phase 4
Recruiting
50 enrolled